As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

The new drugs could become the way forward for medicated weight loss as clinical trials reveal optimistic results ...

Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under ...

GLP-1 drugs might lead people to shun alcohol entirely: or the effect may be more nuanced. People might have one drink to ...

As the GLP-1 trend expands, a 'halo effect' is developing. Consumers in families of GLP-1 users are increasingly eating GLP-1 ...

Association driven by fewer major amputations ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today updated product information for healthcare ...

According to doctors, making a misstep is easier than you may think.

Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...

Food brands are racing into GLP‑1-friendly ready meals, but are these products truly nutritious? We explore protein, fibre, ...

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

As GLP-1 drugs reshape India's weight-loss landscape, they may also be quietly rewriting reproductive outcomes—catching ...